Literature DB >> 2659828

The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations.

K Shinohara1, T M Wheeler, P T Scardino.   

Abstract

Preoperative transrectal ultrasonograms in 70 patients who underwent radical prostatectomy were compared retrospectively to the histological features of whole mount sections of the surgical specimens. In 42 cases (60 per cent) the tumor could be appreciated as a hypoechoic area on the sonogram. In only 1 case did the tumor appear as a hyperechoic area. In the other 27 cases (39 per cent) the tumor was isoechoic and could not be distinguished clearly from the surrounding tissue. The smallest tumor visualized sonographically measured 4.4 mm. in diameter in the surgical specimen. There was a statistically significant correlation among tumor echogenicity, the actual tumor size and the Gleason grade. Although there was a linear correlation between the size (maximum diameter) of the tumor measured by ultrasound and that determined from the histological sections, ultrasonography generally underestimated the size of the tumor, with the maximum diameter measured sonographically being approximately 4.8 mm. smaller than the diameter measured in the whole mount sections. Of 25 nonpalpable (stage A) tumors 9 (36 per cent) were visualized on ultrasound, while of 45 palpable (stage B) tumors 11 (21 per cent) were not. Although most clinically recognized tumors can be appreciated sonographically, the tumors that are visualized tend to be larger, less well differentiated and palpable. These features favor the use of sonography to stage and monitor established prostate cancers, and suggest that tumors detected by sonography in an early detection program are likely to be clinically important cancers.

Entities:  

Mesh:

Year:  1989        PMID: 2659828     DOI: 10.1016/s0022-5347(17)38666-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  41 in total

Review 1.  Methods for volume assessment of prostate cancer.

Authors:  Heinz-Peter Schlemmer; Stefan Corvin
Journal:  Eur Radiol       Date:  2004-02-06       Impact factor: 5.315

Review 2.  [Possibilities of sonographic image fusion: Current developments].

Authors:  E M Jung; D-A Clevert
Journal:  Radiologe       Date:  2015-11       Impact factor: 0.635

Review 3.  When prostate cancer remains undetectable: The dilemma.

Authors:  Mahmoud Othman Mustafa; Louis Pisters
Journal:  Turk J Urol       Date:  2015-03

4.  MR-compatible assistance system for punction in a high-field system: device and feasibility of transgluteal biopsies of the prostate gland.

Authors:  Stephan Zangos; Christopher Herzog; Katrin Eichler; Renate Hammerstingl; Andreas Lukoschek; Stefanie Guthmann; Bernd Gutmann; Uwe Joseph Schoepf; Phillip Costello; Thomas J Vogl
Journal:  Eur Radiol       Date:  2006-10-10       Impact factor: 5.315

Review 5.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

Review 6.  [Sonographic imaging of the prostate].

Authors:  B Schlenker; D A Clevert; G Salomon
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

7.  Correlation of digital rectal examination, prostate specific antigen, and transrectal ultrasound in prostate carcinoma in African Americans.

Authors:  R I Sibley; A F Sibley
Journal:  J Natl Med Assoc       Date:  1997-05       Impact factor: 1.798

Review 8.  Contrast specific imaging in the detection and localization of prostate cancer.

Authors:  Hessel Wijkstra; Margot H Wink; Jean J M C H de la Rosette
Journal:  World J Urol       Date:  2004-10-05       Impact factor: 4.226

9.  The detection of prostatic carcinoma. 4- or 7-MHz transrectal ultrasonography?

Authors:  R Vleeming; J W Noordzij; T M de Reijke; K H Kurth
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

10.  Modalities for imaging of prostate cancer.

Authors:  A H Hou; D Swanson; A B Barqawi
Journal:  Adv Urol       Date:  2010-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.